Loading…
Seres Therapeutics, Inc. is projected to rise to $10.16 by 2027, a +33% move from its current price of $7.63. MCRB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $7.42 | $7.63 | $7.85 | +0.03% |
| May 30 | $7.33 | $7.63 | $7.95 | +0.06% |
| May 31 | $7.27 | $7.64 | $8.03 | +0.09% |
| Jun 1 | $7.21 | $7.64 | $8.09 | +0.12% |
| Jun 2 | $7.17 | $7.64 | $8.15 | +0.15% |
| Jun 3 | $7.13 | $7.64 | $8.20 | +0.18% |
| Jun 4 | $7.09 | $7.65 | $8.25 | +0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.09 | $7.65 | $8.25 | +0.22% |
| Week 2 | $6.88 | $7.66 | $8.53 | +0.43% |
| Week 3 | $6.73 | $7.68 | $8.76 | +0.65% |
| Week 4 | $6.61 | $7.70 | $8.96 | +0.87% |
| Week 5 | $6.51 | $7.71 | $9.14 | +1.08% |
| Week 6 | $6.42 | $7.73 | $9.31 | +1.30% |
| Week 7 | $6.34 | $7.75 | $9.47 | +1.52% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Seres Therapeutics, Inc. is a clinical-stage healthcare company focused on developing biotherapeutics for serious diseases. The company develops SER-155, SER-603, SER-147, live biotherapeutics designed to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation.
The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
Seres Therapeutics, Inc. (MCRB) operates in the Healthcare sector as a clinical-stage company.
A major floor 21.6% below — a decisive break under it would weaken the trend.
The nearest floor, 7.6% below — buyers have tended to step in here.
The nearest ceiling, 17.2% above — a clean break opens room to run.
A major ceiling 109.2% above — clearing it would confirm fresh momentum.
Key MCRB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MCRB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.77 | Sell | $7.71 | Sell |
| MA 10 | $7.73 | Sell | $7.73 | Sell |
| MA 20 | $7.69 | Sell | $7.81 | Sell |
| MA 50 | $8.27 | Sell | $8.49 | Sell |
| MA 100 | $10.30 | Sell | $10.05 | Sell |
| MA 200 | $13.97 | Sell | $12.01 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.90 | Neutral |
| Stoch RSI (14) | 41.61 | Neutral |
| CCI (20) | -21.36 | Neutral |
| Williams %R (14) | -68.85 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | -0.91 | Sell |
| Bollinger %B (20,2) | 0.44 | Neutral |
| Stochastic %K (14) | 31.15 | Neutral |
| TRIX (15) | -0.36 | Sell |
| Awesome (5,34) | -0.20 | Sell |
| Ultimate (7,14,28) | 46.44 | Neutral |
| Momentum (10) | -0.33 | Sell |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 7.79 | Sell |
| ADX (14) | 14.06 | Neutral |
| ATR (14) | 0.22 | Info |
The stock is currently priced at $7.92 with a market cap of $76.7M and a rank of 4393. The 30-day technical picture shows neutral sentiment, with RSI14 at 50. The 50-day simple moving average is $8.31 and the 200-day simple moving average is $14.05.
Support is at $7.05 and resistance at $8.94, with a 30-day price range of $6.53 to $9.60. Annualized volatility is 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.05 | $7.63 | $10.40 | 0% | Neutral | |
| $8.02 | $10.16 | $13.67 | +33% | Bullish | |
| $8.20 | $10.69 | $14.92 | +40% | Bullish | |
| $7.59 | $10.14 | $14.57 | +33% | Bullish | |
| $8.18 | $11.16 | $16.45 | +46% | Bullish | |
| $8.05 | $11.20 | $16.87 | +47% | Bullish | |
| $8.26 | $11.70 | $17.96 | +53% | Bullish | |
| $10.14 | $14.62 | $22.84 | +92% | Bullish | |
| $10.62 | $15.57 | $24.73 | +104% | Bullish | |
| $11.32 | $16.84 | $27.17 | +121% | Bullish | |
| $13.77 | $22.01 | $37.83 | +189% | Bullish | |
| $21.30 | $38.53 | $72.62 | +405% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $7.05 | $7.63 | $9.01 | +0.00% |
| June 2026 | $6.77 | $7.96 | $9.59 | +4.30% |
| July 2026 | $6.62 | $7.85 | $9.59 | -1.40% |
| August 2026 | $6.42 | $7.67 | $9.47 | -2.31% |
| September 2026 | $6.56 | $7.88 | $9.81 | +2.76% |
| October 2026 | $6.67 | $8.05 | $10.11 | +2.22% |
| November 2026 | $6.56 | $7.96 | $10.06 | -1.17% |
| December 2026 | $6.71 | $8.17 | $10.40 | +2.70% |
Click any year to see its month-by-month MCRB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MCRB to range from $7.05 to $10.40 through 2026. The $7.63 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The MCRB price prediction for 2027 points to an average of $10.16 (low $8.02, high $13.67) — a potential gain of +33% on today's $7.63. Momentum favours further upside here.
In 2028, MCRB is projected to trade between $8.20 and $14.92, averaging $10.69 — a potential gain of +40% from today's $7.63. That is up +5% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Seres Therapeutics, Inc.'s 2029 outlook centres on $10.14, within a $7.59 to $14.57 range. That is -5% versus the projected 2028 average. That marks a +33% change versus current levels. Momentum favours further upside here.
By 2030, MCRB could reach as high as $16.45, with a base case around $11.16 and support toward $8.18 — roughly +46% from $7.63. Buyers look set to stay in control over this stretch.
Expect MCRB to range from $8.05 to $16.87 through 2031. The $11.20 average target implies a +47% move from current prices. That is up 0% on the projected 2030 average. Momentum favours further upside here.
The MCRB price prediction for 2032 points to an average of $11.70 (low $8.26, high $17.96) — a potential gain of +53% on today's $7.63. Buyers look set to stay in control over this stretch.
In 2033, MCRB is projected to trade between $10.14 and $22.84, averaging $14.62 — a potential gain of +92% from today's $7.63. That is up +25% on the projected 2032 average. Momentum favours further upside here.
Seres Therapeutics, Inc.'s 2034 outlook centres on $15.57, within a $10.62 to $24.73 range. That is up +6% on the projected 2033 average. That marks a +104% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, MCRB could reach as high as $27.17, with a base case around $16.84 and support toward $11.32 — roughly +121% from $7.63. Momentum favours further upside here.
Expect MCRB to range from $13.77 to $37.83 through 2040. The $22.01 average target implies a +189% move from current prices. That is up +31% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The MCRB price prediction for 2050 points to an average of $38.53 (low $21.30, high $72.62) — a potential gain of +405% on today's $7.63. Momentum favours further upside here.
Investing $1,000 in MCRB today (≈ 131.061599 MCRB) could be worth
$5,049.47
+$4,049.47 (+405%) by 2050 · US Dollar
Based on the average projected MCRB price of $38.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MCRBwould be worth at today's price.
$1,000 invested in MCRB on May 27, 2025 (≈ 138.312586 MCRB) would be worth
$1,055.33
+$55.33 (+5.5%) today · 1.06× · US Dollar
Based on a MCRB entry price of $7.23 vs. today's $7.63.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.66 | $996.08 | -0.4% |
| 1 month ago | $7.32 | $1,042.35 | +4.2% |
| 3 months ago | $8.88 | $859.23 | -14.1% |
| 6 months ago | $17.99 | $424.12 | -57.6% |
| 1 year ago | $7.23 | $1,055.33 | +5.5% |
| All time (5.0y) ago | $403.8 | $18.9 | -98.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MCRB forecast.
Our base-case forecast reaches $15.00 around 2034.
Implied market cap at $15.00: $145.26M
Forecasts indicate a bullish trajectory over the coming years. The 2026 forecast shows an avg of $7.92 with a min of $7.05 and a max of $10.93, sentiment NEUTRAL. By 2030, the avg is $11.57 with a min of $8.45 and a max of $17.12, and a ROI of 46.1 with a BULLISH sentiment.
In 2040, the avg is $22.60 (min $14.04, max $39.06) with a ROI of 185.3 and a BULLISH sentiment, and by 2050 the avg reaches $40.03 (min $21.91, max $75.97) with a ROI of 405.5 and a BULLISH sentiment. These figures reflect a long-run bullish outlook, but they are estimates and not guarantees; actual results depend on clinical progress, regulatory outcomes, and market conditions.
Tap a question to reveal the answer.
2030 forecast shows min $8.45, avg $11.57, max $17.12, ROI 46.1, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward, with avg prices rising to $11.57 by 2030 and $40.03 by 2050, and ROI up to 405.5.
Yes. By 2040 the forecasted avg is $22.60 and max $39.06, with a 2040 min of $14.04.
The current price is $7.92. The 2026 forecast shows an avg of $7.92, with 30-day range $6.53–$9.60 and a nearby support at $7.05.
Forecasts are estimates, not guarantees, and the outlook includes high volatility (annualized 60%) and a small-market-cap environment (market cap $76.7M) that can lead to substantial price fluctuations.
Seres Therapeutics, Inc. Community Discussion
0Share your Seres Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.